Clinical Trial Update: Dyslipidemia in Cardiovascular Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on dyslipidemia in cardiovascular disease reports the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Dyslipidemia | Phase 4 | Status: COMPLETED